Ditazole and platelets. II. Effect of ditazole on in vivo platelet aggregation and bleeding time in rats
- PMID: 18382
- DOI: 10.1159/000214179
Ditazole and platelets. II. Effect of ditazole on in vivo platelet aggregation and bleeding time in rats
Abstract
Ditazole (4,5-diphenyl-2-bis-(2-hydroxyethyl)-aminoxazol) is a new drug shown to inhibit prostaglandin release from rat platelets. The present study indicates that ditazole, at doses similar to those inhibiting prostaglandin formation in rat, inhibits in vivo collagen--but not ADP-induced rat platelet aggregation. In addition, ditazole does not prolong the bleeding time in rats, but even tends to shorten it. This effect could be due to the inhibition of prostaglandin formation at the side of the vascular injury produced to induce bleeding.
Similar articles
-
Ditazole and platelets. I. Effect of ditazole on human platelet function in vitro.Haemostasis. 1977;6(2):127-36. doi: 10.1159/000214172. Haemostasis. 1977. PMID: 16812
-
In vitro investigation on the antiaggregating activity of ditazole.Int J Clin Pharmacol Res. 1984;4(5):341-7. Int J Clin Pharmacol Res. 1984. PMID: 6151552
-
Effect of a single Ditazole dose on platelet aggregation and prostaglandin formation.Int J Clin Pharmacol Res. 1984;4(2):129-36. Int J Clin Pharmacol Res. 1984. PMID: 6147319
-
Ditazole and platelets III. Effect of ditazole on tumor-cell induced thrombocytopenia and on bleeding time in mice.Haemostasis. 1977;6(4):260-5. doi: 10.1159/000214188. Haemostasis. 1977. PMID: 21124
-
Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.Semin Thromb Hemost. 2005 Apr;31(2):129-38. doi: 10.1055/s-2005-869518. Semin Thromb Hemost. 2005. PMID: 15852216 Review.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous